As you know, in spite of all the existing efforts, reasonable cancer therapy is available for only 10-15% of the cancer patients in the world . This lack is evident in the fields of medical, radiation oncology and good palliative and supportive care. This tragic situation should not continue!. For this purpose The ICEDOC is established. It is an independent committee which is not in competition but it encourage full cooperation and coordination with all the existing organizations, societies and authorities. It is not founded to duplicate the existing organizations but to complement them. One of the innovative approaches of ICEDOC is in grouping views and efforts of volunteers oncologists, experts, cancer treatment manufacturers, authorities, administrators and some eminent personalities towards increasing facilities in the existing cancer centers and establishment of more cancer management units all over the world.

So, as it appears from its name, the main objective of the ICEDOC is to increase and to improve cancer management facilities in the world.

The first preliminary manuscript of this statement was formulated by Prof. Dr. Ahmed Elzawawy (Egypt) in April, 1993.

- Not competitors but allies with all.
- With all towards increasing cancer management facilities.
- Classic and innovative approaches.

1.Therapy and drug development group in the second and third world countries It is applied to all kinds of therapy, chemotherapy, radiation therapy, supportive care, etc... Anticancer protocols and combinations could be tailored and modified according to each specific and regional conditions. Also, therapeutic trials could be conducted in selected regions of the second and third world countries, under follow up of volunteers consultants from the ICEDOC and the manufacturers. This hopefully will lead to 1) improvement of cancer treatment reporting of results in these selected areas. 2) To assure the respect of the ethical aspects in conducting these therapeutic trials. Both items 1) and 2) hopefully might improve cancer treatment practice and will be for the benefits of patients with low economic resources. 3) Also, for companies, time could be saved in conducting therapeutic trials and moreover, there might be a probable increase in the scope of information and uses of certain drugs and combinations. Notice that in the ICEDOC, we are practical and romantic in the same time, we cannot involve much, the manufacturers for the sake of our Nobel goals without probable or even sure gain for the companies, we try in every step to combine both the reality and the hopes .

2.Task force for establishment and development of oncology centers, it is the house of volunteer experts and consultants to give advice about how to establish comprehensive oncology units in areas were these facilities are lacking and how to improve centers in case they are already existing. Again the advice should be tailored according to the past, present and prospect of each area.

3.Technology Development & Transfer (The ICEDOC TDT), it will be concerned with the development of technology and research and their transfer in a way that could be applicable and tailored for each area. These different abilities of modifications and tailoring might be also of scientific and economic values for the users, the manufacturers, and the humanity. The ways of transfer should also take into consideration the recent evolving ways of communications and computers.

4.The ICEDOC international relationship and liaison affairs group, also this group will work closely and in conjunction with other groups of the ICEDOC to increase the every day relationship and cooperation with all who would like to cooperate or to coordinate with the ICEDOC. We adopt the concept of open doors for all.

Prof. Dr. Ahmed Elzawawy,
President of ICEDOC
Websites: www.icedoc.net & www.icedoc.org
Emails: worldcooperation@gmail.com & worldcooperation17@gmail.com